IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Evotec Sells Drug Development Arm

11:07 AM MDT | September 18, 2007 |

Alex Scott

Drug discovery firm Evotec (Hamburg, Germany) says it has sold its chemical development business to drug development services group Aptuit (Greenwich, CT) for $64 million in cash. Evotec’s chemical development business is comprised of activities in process research and development, custom preparation, analytical development, pilot plant manufacturing and formulation. The business has a total of about 210 people based in Oxford and Glasgow, U.K. and generated sales in 2006 of EUR €26.8 million ($37.2 million). "This acquisition continues Aptuit's...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa